🇺🇸 FDA

Company profile · Sponsor

Alaunos

Alaunos Therapeutics

TCRT · NYSE pharma FORT LAUDERDALE, FL, USA
Pipeline
24
Drugs
0
Patents
0

Quick answer

Alaunos (TCRT) is a pharma company. headquartered in FORT LAUDERDALE, FL, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker TCRT
Exchange NYSE
Company type pharma
Headquarters FORT LAUDERDALE, FL, USA
SEC CIK 0001107421

Pipeline (24)

Search pipeline →

  1. Carboplatin

    Alaunos

    Extensive-Stage Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  2. doxorubicin in combination with palifosfamide-tris

    Alaunos

    Soft Tissue Sarcoma

    phase 3 small molecule completed

    1 trial

  3. Ad-RTS-hIL-12

    Alaunos

    Metastatic Breast Cancer

    phase 2 mab terminated

    1 trial

  4. Ad-RTS-hIL-12

    Alaunos

    Pediatric Brain Tumor

    phase 2 mab terminated

    1 trial

  5. Ad-RTS-hIL-12

    Alaunos

    Glioblastoma

    phase 2 mab completed

    3 trials

  6. Ad-RTS-hIL-12 and Veledimex

    Alaunos

    Breast Cancer Nos Metastatic Recurrent

    phase 2 gene therapy terminated

    1 trial

  7. Darinaparsin

    Alaunos

    Hematologic Neoplasms

    phase 2 small molecule completed

    1 trial

  8. Darinaparsin

    Alaunos

    HEPATOCELLULAR CARCINOMA

    phase 2 small molecule active

    1 trial

  9. Darinaparson

    Alaunos

    Multiple Myeloma

    phase 2 small molecule active

    1 trial

  10. INXN-2001

    Alaunos

    Melanoma

    phase 2 mab completed

    1 trial

  11. Indibulin

    Alaunos

    Metastatic Breast Cancer

    phase 2 small molecule active

    1 trial

  12. Neoantigen specific TCR-T cell drug product

    Alaunos

    Gynecologic Cancer

    phase 2 mab terminated

    1 trial

  13. Palifosfamide Tris and Doxorubicin

    Alaunos

    Soft Tissue Sarcoma

    phase 2 small molecule active

    1 trial

  14. ZIO-101 (Darinaparsin)

    Alaunos

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  15. ZIO-201

    Alaunos

    Advanced Sarcoma

    phase 2 small molecule completed

    1 trial

  16. indibulin

    Alaunos

    Advanced Solid Tumors

    phase 2 small molecule active

    2 trials

  17. palifosfamide

    Alaunos

    Adult Central Nervous System Germ Cell Tumor

    phase 2 small molecule terminated

    1 trial

  18. Ad-RTS-hIL-12

    Alaunos

    Glioblastoma Multiforme

    phase 1 mab completed

    1 trial

  19. IL-2

    Alaunos

    Lymphoma

    phase 1 small molecule completed

    1 trial

  20. INXN-1001

    Alaunos

    Melanoma

    phase 1 small molecule completed

    1 trial

  21. ZIO-101

    Alaunos

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  22. ZIO-101 (Darinaparsin)

    Alaunos

    Acute Leukemia

    phase 1 small molecule completed

    1 trial

  23. ZIO-101 (Darinaparsin)

    Alaunos

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  24. ZIO-101-C (Darinaparsin)

    Alaunos

    Advanced Cancer

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Alaunos?

Alaunos (TCRT) is a pharma company. headquartered in FORT LAUDERDALE, FL, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Alaunos sponsor?

We track 24 ClinicalTrials.gov-linked programs for Alaunos, including Carboplatin and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Alaunos company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.